GL1X · GenesisL1 explorer

MolNFT v1 · #15015 · protein

Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RNA. crystal structures of native Fab and three Fab-mononucleotide complexes

1MRF · IGG2B-kappa JEL103 Fab (light chain): “Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RNA. crystal…”. X-ray diffraction, 2 ligands (DI, ZN), 3 pockets (best druggability 0.56). MolNFT…

PDB
1MRF
Type
protein
Length
421 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
IGG2B-kappa JEL103 Fab (light chain); IGG2B-kappa JEL103 Fab (heavy chain)
Ligands
DI, ZN
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LIGG2B-kappa JEL103 Fab (light chain)protein2166% helix, 53% strand—
HIGG2B-kappa JEL103 Fab (heavy chain)protein2059% helix, 55% strand—

Ligands and binding sites

  • DI · 2'-deoxyinosine-5'-monophosphate · ligand · chains L, H
  • ZN · Zinc ion · metal · chains L
  • IMD · Imidazole · additive · chains L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13700.560.7552empty
21000.390.7618DI
3980.330.7223empty

Interfaces

1 interface between chains.

  • L–H · 1649 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1MRF · Preparation, characterization and crystallization of an antibody Fab fragment that… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.